Abstract:Abstract Background: The rapidly growing research in leukemia has provided unequivocal proof that cancer stem cells exist in acute myeloid leukemia. However, the mechanisms of the growth and self-renewal of acute myeloid leukemia stem cells (LSCs), which play an important role in the development of AML, were still elusive. Methods: We first used a trained stemness index model based on a recently described machine learning method one-class logistic regression (OCLR) to score AML samples. We then obtained the mRNA expression based-index (mRNAsi), DNA methylation based-index (mDNAsi), and epigenetic regulation based-index (EREG-mRNAsi). With the acquired three stemness indices, we investigated the relationship between the stemness index and the tumor immune microenvironment/somatic mutation, clinical characteristics of AML patients. Furthermore, a weighted gene co-expression network analysis (WGCNA) and protein-protein interaction (PPI) network were performed to obtain key genes associated with the stemness index. Bedsides, GO and KEGG enrichment analysis was performed to explore the biological functions. Finally, we validated the key genes by applying it to the Oncomine and GEO datasets.Result: The results suggested that EREG-mRNAsi might accurately predict overall survival (OS) in AML patients from TCGA, while the mRNAsi and mDNAsi was not significantly statistically associated with the OS. Furthermore, the mRNAsi was significantly correlated with the clinical characteristics of the FAB category, age, gender, immune score, WT1, and CEBPA mutation. Additionally, the EREG-mRNAsi was significantly associated with the cytogenetics risk category, TP53 mutation. The mDNAsi was significantly associated with the FAB-category, NPM1, IDH1, IDH2, and DNMT3A mutation. Several key genes related to the stemness index of AML were indicated to be possible and promising therapeutic targets for inhibiting LSCs in AML.Conclusions: Our research based on machine learning and WGCNA analysis revealed a set of key genes contributed to the stemness index of AML. These genes may become therapeutic targets to inhibit the LSCs of AML in the future.

Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells

3147 – SPHINGOSINE-1-PHOSPHATE RECEPTOR 3 SIGNALING DEPLETES LEUKEMIA STEM CELLS BY INDUCING DIFFERENTIATION

The Non-Cell-autonomous Function of ID1 Promotes AML Progression Via ANGPTL7 from the Microenvironment.

S1PR1 mediates anti‑apoptotic/pro‑proliferative processes in human acute myeloid leukemia cells.

Re-Evaluation of Various Molecular Targets Located on Cd34(+)Cd38(-)Lin(-) Leukemia Stem Cells and Other Cell Subsets in Pediatric Acute Myeloid Leukemia

Molecular Mechanisms for Stemness Maintenance of Acute Myeloid Leukemia Stem Cells

[Progress in the Studies of Acute Myelogenous Leukemia Stem Cell].

Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway

[Pml-Rarα and P21 Are Key Factors for Maintaining Acute Promyelocytic Leukemia Stem Cells Survival].

Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia

PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway

SLED1 Promoting Cell Proliferation and Inhibiting Apoptosis in Acute Myeloid Leukemia: a Study

3138 – A TWO-STEP IN VIVO CRISPR SCREEN UNVEILS PERVASIVE RNA-BINDING PROTEIN DEPENDENCIES FOR LEUKEMIC STEM CELLS AND IDENTIFIES ELAVL1 AS A THERAPEUTIC TARGET

Machine Learning and Integrative Analysis Reveals Stemness Index-associated Signature in Acute Myeloid Leukemia

T-ALL Leukemia Stem Cell 'stemness' is Epigenetically Controlled by the Master Regulator SPI1

A novel stemness classification in acute myeloid leukemia by the stemness index and the identification of cancer stem cell-related biomarkers

C-Mpl is a Candidate Surface Marker and Confers Self-Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells

Six1 Regulates Leukemia Stem Cell Maintenance in Acute Myeloid Leukemia

[Biological Behavior of Stromal Cell-Derived Factor-1 on Migration, Adhesion and Apoptosis in Different Kinds of AML Cell Lines].

Decoding M6a RNA Methylome Identifies PRMT6-regulated Lipid Transport Promoting AML Stem Cell Maintenance

A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia